Completed
An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis
NCT03229252
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
- Locations
-
- University of Calgary Heritage Medical Research Center Calgary, Alberta, Canada
- Ottawa Hospital Research Institute/Institut de Recherche de l'Hospital d'Ottawa Ottawa, Ontario, Canada
- Saint Michael's Hospital Toronto, Ontario, Canada
- Hospices Civils de Lyon (HCL) Pierre-Bénite, Auvergne-Rhône-Alpes, France